{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Valsartan  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Valsartan. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Valsartan  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "valsartan",
    "trial_2_text": "Valsartan  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Valsartan Supplement: 60 participants will take Valsartan 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Valsartan. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Valsartan  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.21437668800354004,
      "78": 0.2042650282382965,
      "123": 0.18309450149536133,
      "20": 0.18122662603855133,
      "173": 0.16400904953479767,
      "177": 0.12819215655326843,
      "9": 0.11280262470245361,
      "17": 0.11251039057970047,
      "37": 0.09970234334468842,
      "180": 0.09804175049066544,
      "21": 0.09712087363004684,
      "85": 0.09511515498161316,
      "14": 0.08958198130130768,
      "151": 0.08695685118436813,
      "29": 0.08264946192502975,
      "228": 0.08003108203411102,
      "46": 0.07907472550868988,
      "2": 0.07582075148820877,
      "189": 0.07441004365682602,
      "200": 0.07422638684511185,
      "76": 0.07098852843046188,
      "350": 0.0692669227719307,
      "61": 0.06854000687599182,
      "114": 0.06805264949798584,
      "28": 0.06698848307132721,
      "67": 0.0645730122923851,
      "188": 0.06405919045209885,
      "121": 0.061000414192676544,
      "96": 0.0606289766728878,
      "122": 0.06006350740790367,
      "27": 0.059231434017419815,
      "49": 0.05898379161953926,
      "104": 0.058759961277246475,
      "142": 0.057853925973176956,
      "126": 0.057341109961271286,
      "164": 0.05661766231060028,
      "64": 0.05629188194870949,
      "243": 0.05488855391740799,
      "86": 0.05430424213409424,
      "179": 0.054226428270339966,
      "77": 0.05357404053211212,
      "356": 0.0529123991727829,
      "138": 0.052855636924505234,
      "276": 0.04960836470127106,
      "131": 0.04853004217147827,
      "269": 0.04800060763955116,
      "130": 0.04774920642375946,
      "79": 0.04621100425720215,
      "30": 0.04491308704018593,
      "5": 0.044749993830919266,
      "193": 0.0445575974881649,
      "361": 0.04360107704997063,
      "239": 0.043045274913311005,
      "31": 0.042909830808639526,
      "139": 0.042584069073200226,
      "18": 0.04251633957028389,
      "186": 0.041647374629974365,
      "147": 0.04015384241938591,
      "72": 0.03906913474202156,
      "132": 0.038940783590078354,
      "118": 0.03859894350171089,
      "101": 0.03826867416501045,
      "194": 0.038160499185323715,
      "92": 0.03808073326945305,
      "35": 0.03789548575878143,
      "371": 0.03787870332598686,
      "249": 0.03746899962425232,
      "221": 0.03720983862876892,
      "68": 0.03699009492993355,
      "144": 0.03586913272738457,
      "456": 0.03576221689581871,
      "396": 0.03554176539182663,
      "4": 0.03540433198213577,
      "199": 0.035362642258405685,
      "253": 0.03533487021923065,
      "11": 0.03510027751326561,
      "22": 0.03495298698544502,
      "466": 0.034585777670145035,
      "288": 0.03441079333424568,
      "339": 0.03425656259059906,
      "33": 0.03374204784631729,
      "38": 0.03361504524946213,
      "261": 0.033397428691387177,
      "102": 0.03319019451737404,
      "382": 0.03306165710091591,
      "116": 0.03213539347052574,
      "191": 0.03185976669192314,
      "154": 0.03165652975440025,
      "152": 0.03145540505647659,
      "133": 0.03131524845957756,
      "393": 0.03095039166510105,
      "256": 0.03090568445622921,
      "310": 0.030780227854847908,
      "394": 0.030677950009703636,
      "75": 0.03067406639456749,
      "262": 0.030399823561310768,
      "23": 0.02995298057794571,
      "282": 0.029901476576924324,
      "213": 0.029862647876143456,
      "254": 0.02984217181801796
    },
    "trial_2_ae": {
      "87": 0.21437668800354004,
      "78": 0.2042650282382965,
      "123": 0.18309450149536133,
      "20": 0.18122662603855133,
      "173": 0.16400904953479767,
      "177": 0.12819215655326843,
      "9": 0.11280262470245361,
      "17": 0.11251039057970047,
      "37": 0.09970234334468842,
      "180": 0.09804175049066544,
      "21": 0.09712087363004684,
      "85": 0.09511515498161316,
      "14": 0.08958198130130768,
      "151": 0.08695685118436813,
      "29": 0.08264946192502975,
      "228": 0.08003108203411102,
      "46": 0.07907472550868988,
      "2": 0.07582075148820877,
      "189": 0.07441004365682602,
      "200": 0.07422638684511185,
      "76": 0.07098852843046188,
      "350": 0.0692669227719307,
      "61": 0.06854000687599182,
      "114": 0.06805264949798584,
      "28": 0.06698848307132721,
      "67": 0.0645730122923851,
      "188": 0.06405919045209885,
      "121": 0.061000414192676544,
      "96": 0.0606289766728878,
      "122": 0.06006350740790367,
      "27": 0.059231434017419815,
      "49": 0.05898379161953926,
      "104": 0.058759961277246475,
      "142": 0.057853925973176956,
      "126": 0.057341109961271286,
      "164": 0.05661766231060028,
      "64": 0.05629188194870949,
      "243": 0.05488855391740799,
      "86": 0.05430424213409424,
      "179": 0.054226428270339966,
      "77": 0.05357404053211212,
      "356": 0.0529123991727829,
      "138": 0.052855636924505234,
      "276": 0.04960836470127106,
      "131": 0.04853004217147827,
      "269": 0.04800060763955116,
      "130": 0.04774920642375946,
      "79": 0.04621100425720215,
      "30": 0.04491308704018593,
      "5": 0.044749993830919266,
      "193": 0.0445575974881649,
      "361": 0.04360107704997063,
      "239": 0.043045274913311005,
      "31": 0.042909830808639526,
      "139": 0.042584069073200226,
      "18": 0.04251633957028389,
      "186": 0.041647374629974365,
      "147": 0.04015384241938591,
      "72": 0.03906913474202156,
      "132": 0.038940783590078354,
      "118": 0.03859894350171089,
      "101": 0.03826867416501045,
      "194": 0.038160499185323715,
      "92": 0.03808073326945305,
      "35": 0.03789548575878143,
      "371": 0.03787870332598686,
      "249": 0.03746899962425232,
      "221": 0.03720983862876892,
      "68": 0.03699009492993355,
      "144": 0.03586913272738457,
      "456": 0.03576221689581871,
      "396": 0.03554176539182663,
      "4": 0.03540433198213577,
      "199": 0.035362642258405685,
      "253": 0.03533487021923065,
      "11": 0.03510027751326561,
      "22": 0.03495298698544502,
      "466": 0.034585777670145035,
      "288": 0.03441079333424568,
      "339": 0.03425656259059906,
      "33": 0.03374204784631729,
      "38": 0.03361504524946213,
      "261": 0.033397428691387177,
      "102": 0.03319019451737404,
      "382": 0.03306165710091591,
      "116": 0.03213539347052574,
      "191": 0.03185976669192314,
      "154": 0.03165652975440025,
      "152": 0.03145540505647659,
      "133": 0.03131524845957756,
      "393": 0.03095039166510105,
      "256": 0.03090568445622921,
      "310": 0.030780227854847908,
      "394": 0.030677950009703636,
      "75": 0.03067406639456749,
      "262": 0.030399823561310768,
      "23": 0.02995298057794571,
      "282": 0.029901476576924324,
      "213": 0.029862647876143456,
      "254": 0.02984217181801796
    }
  },
  "safety": {
    "trial_1_safety": 0.3582867681980133,
    "trial_2_safety": 0.3582867681980133
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.48117169737815857
  }
}